can semaglutide cause indigestion Ozempic and Heartburn: What's the Connection? Ozempic: Semaglutide is a GLP-1

Key Findings: No significant difference in overall adverse events between the two drugs Tirzepatide increased treatment discontinuation by 32% a crucial real-world consideration Better glycemic control (HbA1c targets) with tirzepatide, especially in early-stage disease Efficacy vs tolerability trade-off remains central to treatment decisions Clinical Insight: While tirzepatide offers strong metabolic benefits, our analysis highlights a critical reality: A treatment is only effective if patients can tolerate and continue it

The result is countless policy and price changes and a lot of confusion

Although shown to have good results, at present, authorities such as the FDA have approved GLP-1 medicines only as injections or tablets, not patches

Some researchers prefer different concentrations for various reasons